Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Administrative law (3)
- APA (1)
- Business Roundtable (1)
- Chevron deference (1)
- Cost-benefit analysis (1)
-
- Court of Appeals opinion (1)
- Courts (1)
- Daubert (1)
- Delegation (1)
- Drugmakers (1)
- FDCA (1)
- First Amendment (1)
- Judicial review (1)
- National Securities Market Improvement Act (1)
- Off-label (1)
- Pharmaceutical (1)
- Premarket approval regime (1)
- Prior restraint (1)
- Regulation (1)
- Rule of law (1)
- Securities regulation (1)
- Supreme Court's Vermont Yankee decision (1)
- Publication
Articles 1 - 5 of 5
Full-Text Articles in Law
Safe At Any Speed: Robert Ahdieh’S Take On Cost-Benefit Analysis In Financial Markets, Jack M. Beermann
Safe At Any Speed: Robert Ahdieh’S Take On Cost-Benefit Analysis In Financial Markets, Jack M. Beermann
Shorter Faculty Works
When I saw the title of Robert Ahdieh’s recent article, Reanalyzing Cost-Benefit Analysis: Toward a Framework of Function(s) and Form(s), I thought, “oh no, not another article about CBA.” Knowing Professor Adhieh’s work, I took a flyer and read it anyway, and boy was I happy with my decision. This is a great article which should be of interest to anyone involved in administrative law, securities regulation and policy analysis more generally. Cost-benefit analysis has become an important regulatory tool, and Professor Adhieh’s article makes a valuable contribution to the literature on the special analysis required under Section 106 …
Chevron At The Roberts Court: Still Failing After All These Years, Jack M. Beermann
Chevron At The Roberts Court: Still Failing After All These Years, Jack M. Beermann
Faculty Scholarship
This article looks at how Chevron deference has fared at the Supreme Court since John G. Roberts became Chief Justice. The article looks at Chevron deference at the Roberts Court from three distinct angles. First, the voting records of individual Justices in cases citing Chevron are examined to shed light on the strength of each Justice’s commitment to deference to agency statutory construction. Second, a select sample of opinions citing Chevron are qualitatively examined to see whether the Roberts Court has been any more successful than its predecessor in constructing a coherent Chevron doctrine. Third, the article looks closely at …
The Return Of The King: The Unsavory Origins Of Administrative Law, Gary S. Lawson
The Return Of The King: The Unsavory Origins Of Administrative Law, Gary S. Lawson
Faculty Scholarship
Philip Hamburger’s Is Administrative Law Unlawful? is a truly brilliant and important book. In a prodigious feat of scholarship, Professor Hamburger uncovers the British and civil law antecedents of modern American administrative law, showing that contemporary administrative law “is really just the most recent manifestation of a recurring problem.” That problem is the problem of power: its temptations, its dangers, and its tendency to corrupt. Administrative law, far from being a distinctive product of modernity, is thus the “contemporary expression of the old tendency toward absolute power – toward consolidated power outside and above the law.” It represents precisely the …
Rethinking Notice, Jack M. Beermann
Rethinking Notice, Jack M. Beermann
Shorter Faculty Works
APA § 553 (b)(3) requires agencies engaged in informal rulemaking to provide notice of "either the terms or substance of the proposed rule or a description of the subjects and issues involved." In most cases, agencies publish the complete text of their proposed rules, together with a preamble describing the need for the rule and the major considerations of policy and law that are raised by the proposal. Comments often convince agencies to make changes to their proposed rules. This, of course, is the whole point of the process. Difficulties arise, however, when, in reaction to comments, agencies promulgate rules …
When Truth Cannot Be Presumed: The Regulation Of Drug Promotion Under An Expanding First Amendment, Christopher Robertson
When Truth Cannot Be Presumed: The Regulation Of Drug Promotion Under An Expanding First Amendment, Christopher Robertson
Faculty Scholarship
The Food, Drug, and Cosmetic Act (FDCA) requires that, prior to marketing a drug, the manufacturer must prove that it is safe and effective for the manufacturer’s intended uses, as shown on the proposed label. Nonetheless, physicians may prescribe drugs for other “off-label” uses, and often do so. Still, manufacturers have not been allowed to promote the unproven uses in advertisements or sales pitches.
This regime is now precarious due to an onslaught of scholarly critiques, a series of Supreme Court decisions that enlarge the First Amendment, and a landmark court of appeals decision holding that the First Amendment precludes …